Exosome-based Tumor Therapy: Opportunities and Challenges
Journal:
Current Drug Metabolism
Volume:
21
Page:
339-351
Author(s):
Chunmei Li, Xiaoming Hou, Peng Zhang, Juan Li, Xiaoguang Liu, Yuping Wang, Quanlin Guan and Yongning Zhou*
The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas
Journal:
Current Drug Targets
Volume:
21
Page:
946-961
Author(s):
Csongor György Lengyel*, Sara Cecilia Altuna, Baker Shalal Habeeb, Dario Trapani and Shah Zeb Khan
Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas
Journal:
Current Drug Targets
Volume:
21
Page:
974-995
Author(s):
Cécile Le Page*, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher and Anne-Marie Mes-Masson
Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers
Journal:
Current Drug Targets
Volume:
21
Page:
1008-1025
Author(s):
A. Gouri*, B. Benarba, A. Dekaken, H. Aoures and S. Benharkat
Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer
Journal:
Current Drug Targets
Volume:
21
Page:
910-921
Author(s):
Esteban Ferreiro , Belén López de Uralde , Rita Abreu , Juan A García-Velasco and Elkin Muñoz *
Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Journal:
Current Drug Targets
Volume:
21
Page:
864-891
Author(s):
Devendra Kumar, Sahil Sharma, Sourav Kalra, Gurpreet Singh, Vikramdeep Monga and Bhupinder Kumar*
ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors
Journal:
Current Drug Targets
Volume:
21
Page:
892-901
Author(s):
Ana Luiza Ataide Carneiro de Paula Gonzaga , Vitória Andrade Palmeira , Thomas Felipe Silva Ribeiro , Larissa Braga Costa , Karla Emília de Sá Rodrigues and Ana Cristina Simões-e-Silva *
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?
Journal:
Current Drug Targets
Volume:
21
Page:
1026-1033
Author(s):
Khalid El Bairi*, Said Afqir and Mariam Amrani
Curcumin Sensitizes Cancers Towards TRAIL-induced Apoptosis via Extrinsic and Intrinsic Apoptotic Pathways
Journal:
Current Drug Targets
Volume:
21
Page:
849-854
Author(s):
Siew Ching Ngai*
Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response
Journal:
Current Drug Targets
Volume:
21
Page:
996-1007
Author(s):
Soumaya Souid*, Dorra Aissaoui, Najet Srairi-Abid and Khadija Essafi-Benkhadir